These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21112412)

  • 1. Mitochondrial pharma-Q-genomics: targeting the OXPHOS cytochrome b.
    Gómez-Durán A; Pacheu-Grau D; López-Pérez MJ; Montoya J; Ruiz-Pesini E
    Drug Discov Today; 2011 Mar; 16(5-6):176-80. PubMed ID: 21112412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of genomics on the path to personalized medicine.
    Tremblay J; Hamet P
    Metabolism; 2013 Jan; 62 Suppl 1():S2-5. PubMed ID: 23021037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A piece in the puzzle of personalized medicine.
    Kroemer HK; Meyer zu Schwabedissen HE
    Clin Pharmacol Ther; 2010 Jan; 87(1):19-20. PubMed ID: 20019696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evidence basis for coenzyme Q therapy in oxidative phosphorylation disease.
    Haas RH
    Mitochondrion; 2007 Jun; 7 Suppl():S136-45. PubMed ID: 17485245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Translational approach for pharmacogenomics and personalized medicine].
    Zhang W; Zhou HH
    Yao Xue Xue Bao; 2011 Jan; 46(1):1-5. PubMed ID: 21465801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DMET microarray technology for pharmacogenomics-based personalized medicine.
    Burmester JK; Sedova M; Shapero MH; Mansfield E
    Methods Mol Biol; 2010; 632():99-124. PubMed ID: 20217574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unmasking the causes of multifactorial disorders: OXPHOS differences between mitochondrial haplogroups.
    Gómez-Durán A; Pacheu-Grau D; López-Gallardo E; Díez-Sánchez C; Montoya J; López-Pérez MJ; Ruiz-Pesini E
    Hum Mol Genet; 2010 Sep; 19(17):3343-53. PubMed ID: 20566709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacogenomics: the quest for individualized therapy].
    López-López M; Guerrero-Camacho JL; Familiar-López IM; Jung-Cook H; Corona-Vázquez T; Alonso-Vilatela ME
    Rev Neurol; 2004 Dec 1-15; 39(11):1063-71. PubMed ID: 15597270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The integration of personalized and systems medicine: bioinformatics support for pharmacogenomics and drug discovery.
    Yan Q
    Methods Mol Biol; 2008; 448():1-19. PubMed ID: 18370227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacometabonomics, pharmacogenomics and personalized medicine.
    Guţiu IA; Andrieş A; Mircioiu C; Rădulescu F; Georgescu AM; Cioacă D
    Rom J Intern Med; 2010; 48(2):187-91. PubMed ID: 21428184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combat against cancer with science and medicine.
    Chow LW; Toi M
    Expert Opin Investig Drugs; 2010 Apr; 19 Suppl 1():S3-4. PubMed ID: 20374027
    [No Abstract]   [Full Text] [Related]  

  • 12. Toward personalized medicine in the neuropsychiatric field.
    Wong EH; Fox JC; Ng MY; Lee CM
    Int Rev Neurobiol; 2011; 101():329-49. PubMed ID: 22050858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coenzyme Q can control the efficiency of oxidative phosphorylation.
    Battino M; Fato R; Parenti-Castelli G; Lenaz G
    Int J Tissue React; 1990; 12(3):137-44. PubMed ID: 2276890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative genomics of the oxidative phosphorylation system in fungi.
    Lavín JL; Oguiza JA; Ramírez L; Pisabarro AG
    Fungal Genet Biol; 2008 Sep; 45(9):1248-56. PubMed ID: 18647654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rheumatoid arthritis: problems and significance of personalized medicine].
    Ter Arkh; 2012; 84(5):5-9. PubMed ID: 22830204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro-oxidant mitochondrial matrix-targeted ubiquinone MitoQ10 acts as anti-oxidant at retarded electron transport or proton pumping within Complex I.
    Plecitá-Hlavatá L; Jezek J; Jezek P
    Int J Biochem Cell Biol; 2009; 41(8-9):1697-707. PubMed ID: 19433311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquinone accumulates in the mitochondria of yeast mutated in the ubiquinone binding protein, Qcr8p.
    Hagerman RA; Waring NJ; Willis RA; Hagerman AE
    Biochem Biophys Res Commun; 2006 May; 344(1):241-5. PubMed ID: 16597436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial polypeptides of the oxidative phosphorylation pathway as potential new targets for anti-cancer therapy.
    Tarantul VZ; Hunsmann G
    Med Hypotheses; 2001 Mar; 56(3):386-7. PubMed ID: 11359366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative proteomics analysis of rat mitochondria from the cerebral cortex and hippocampus in response to antipsychotic medications.
    Ji B; La Y; Gao L; Zhu H; Tian N; Zhang M; Yang Y; Zhao X; Tang R; Ma G; Zhou J; Meng J; Ma J; Zhang Z; Li H; Feng G; Wang Y; He L; Wan C
    J Proteome Res; 2009 Jul; 8(7):3633-41. PubMed ID: 19441803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial medicine--molecular pathology of defective oxidative phosphorylation.
    Fosslien E
    Ann Clin Lab Sci; 2001 Jan; 31(1):25-67. PubMed ID: 11314862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.